AXEL Health Solutions; was established on September 7, 2017 to work on especially market access strategy building, preparation of reimbursement dossiers, pharmacoeconomic analysis and economic models. Ayşen Şentürk is the founder and General Manager of the company. Ayşen Şentürk had been a reimbursement committee member while she had been working at Ministry o Finance. She has experince in Government, pharmaceutical industry and consultancy.
After graduating from Hacettepe University, Faculty of Economics and Administrative Sciences, Department of Health Administration in 2003, she completed her master's degree in Hospital Management from Gazi University, Institute of Social Sciences, Department of Business Administration in 2009. At the same time in 2009, she completed "Health Economics and Pharmacoeconomics" program at Hacettepe University Faculty of Pharmacy. She completed her master thesis on "The Effect of Drug Reimbursement Policies on Drug Expenditures in Social Security System" and her first academic thesis study in this field. Between 2004 and 2009, she worked as a Health Economics Specialist in the General Directorate of Budget and Financial Control of the Ministry of Finance. Then, she worked as the Health Economics Manager at Bayer Pharmaceuticals between 2009-2012. Between 2013 and 2017 she worked in POLAR Health Consultancy Company as a Health Economics & Policy Consultant and Corporate Relations Consultant. As of September 2017, she has established her own company named Axel Health Solutions and she is still working in this position. From 2005 to 2009, she served as a founding member of the Reimbursement Commission, member of the Health Services Pricing Commission, and as an expert in the preparation of the General Health Insurance and Health Implementation Communiqué. She has worked as a poster editor in the field of pharmaceutical and medical equipment / devices in many national and international conferences, and as an assistant editor in the book entitled “Drug Pricing and Refund Policies “published in 2017. As of 2013, she is a reserve member of the Board of Health Economics and Policy Association.